US$ 22.33
before after glp 1 26f, 5'1 GLP-1/GIP Results After 1, 3,
Description
GLP-1 drugs linked to lower risk for dementia in older adults with diabetes: Study A new study found that adults over the age of 60 and on a GLP-1 medication reduced their likelihood of developing dementia by 23 to 44%, depending which medication they were on

Ingredients Supplement Facts Serving Size: 2 Capsules Servings Per Container: 30 Amount Per Serving: Vitamin B6 (as Pyridoxine HCI) 20mg Vitamin B12 (as Methylcobalamin) 100mcg Chromium (as Chromium Picolinate) - 250mcg GPL-1 ACTIVATOR Sreenselect* Phytosome* (Green Tea Leaf Extract) 300mg Dihydroberberine (as Glucovantage*) 200mg GBBGO* (Gamma-Butyrobetaine HCI) 30mg Black Pepper fruit extract 10:1 5mg Other Ingredients: Microcrystalline Cellulose, Vegetable Capsule, Magnesium Stearate

With the ever-increasing number of patients being prescribed GLP-1 RAs, more research needs to be conducted to investigate their potential impact in other areas of healthcare
These findings are consistent with data accessed on August 27, 2025
Wegovy and Ozempic Health Concerns Wegovy (semaglutide) is a higher dose version of the blockbuster drug Ozempic, which was initially approved for the treatment of people with Type 2 diabetes, and is part of a popular new class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1RAs)
